Analysis of CT features and quantitative texture analysis in patients with lung adenocarcinoma: a correlation with EGFR mutations and survival rates

被引:53
|
作者
Sacconi, B. [1 ]
Anzidei, M. [1 ]
Leonardi, A. [1 ]
Boni, F. [1 ]
Saba, L. [2 ]
Scipione, R. [1 ]
Anile, M. [3 ]
Rengo, M. [4 ]
Longo, F. [5 ]
Bezzi, M. [1 ]
Venuta, F. [3 ]
Napoli, A. [1 ]
Laghi, A. [4 ]
Catalano, C. [1 ]
机构
[1] Sapienza Univ Rome, Dept Radiol Oncol & Anatomopathol Sci Radiol, Rome, Italy
[2] AOU Cagliari Polo Monserrato, Dept Radiol, Monserrato, Italy
[3] Sapienza Univ Rome, Dept Thorac Surg, Rome, Italy
[4] Sapienza Univ Rome Polo Pontino, Dept Radiol Oncol & Anatomopathol Sci Radiol, Latina, Italy
[5] Sapienza Univ Rome, Dept Radiol Oncol & Anatomopathol Sci Oncol, Latina, Italy
关键词
IMAGING BIOMARKER; PROGNOSTIC VALUE; CANCER; TUMOR; CHEMORADIOTHERAPY; HETEROGENEITY; GENOMICS;
D O I
10.1016/j.crad.2017.01.015
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: To investigate the correlation between conventional computed tomography (CT) features, quantitative texture analysis (QTA), epidermal growth factor receptor (EGFR) mutations, and survival rates in patients with lung adenocarcinoma. MATERIALS AND METHODS: Sixty-eight patients were evaluated for conventional CT features and QTA in this retrospective study. A multiple logistic regression analysis and receiver operating characteristics (ROC) curve analysis versus death and EGFR status was performed for CT features and QTA in order to assess correlation between CT features, QTA, EGFR mutations, and survival rates. A p-value < 0.05 was regarded to indicate a statistically significant association. RESULTS: An EGFR mutation was identified in 26/68 tumours (38.2%). A negative association was found between EGFR mutation and emphysema (p < 0.0001) whereas a positive correlation was found with necrosis (p = 0.017), air bronchogram (p = 0.0304), and locoregional infiltration (p = 0.0018). Mean, standard deviation, and skewness were found to have significant correlation with EGFR mutation (p = 0.0001; p = 0.0001; p = 0.0459; Fig 3). The only parameter correlated with the event death was entropy (r = 0.2708; p = 0.0329). CONCLUSION: Both qualitative and quantitative analysis disclosed potential associations between CT features and QTA parameters, EGFR mutations and prognosis; these correlations need to be confirmed in larger studies to be used as imaging biomarkers in the management of patients affected by lung adenocarcinoma. (C) 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:443 / 450
页数:8
相关论文
共 50 条
  • [21] Correlation between CT Morphology at the Diagnosis and EGFR Status in Patients with Adenocarcinoma of the Lung
    Mencoboni, M.
    Romani, A.
    Filiberti, R.
    Brianti, A.
    Taveggia, P.
    Bergaglio, M.
    Schettini, D.
    Gandolfo, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2317 - S2317
  • [22] Correlation between F-18 FDG PET/CT and EGFR mutations in lung adenocarcinoma
    Park, Sonya Youngju
    Yoo, Ie Ryung
    Park, Hye Lim
    Choi, Woo Hee
    Han, Eun Ji
    Kim, Sung Hoon
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [23] Prognostic Impact of EGFR Mutation in Patients with Surgically Resected Lung Adenocarcinoma; Analysis about Subtypes of EGFR Mutations
    Kawaguchi, Yohei
    Okano, Tetsuya
    Imai, Ken Taro
    Maehara, Sachio
    Junichi, Maeda
    Yoshida, Koichi
    Hagiwara, Masaru
    Kakihana, Masatoshi
    Kajiwara, Naohiro
    Ohira, Tatsuo
    Ikeda, Norihiko
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S751 - S752
  • [24] Correlation of Survival Rates with CT Texture Changes After Radiation Therapy for Lung Cancer
    Paul, J.
    Zheng, C.
    Hao, Y.
    Gore, E. M.
    Li, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S185 - S185
  • [25] Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma
    Tomonaga, Nanae
    Nakamura, Yoichi
    Yamaguchi, Hiroyuki
    Ikeda, Takaya
    Mizoguchi, Kosuke
    Motoshima, Kohei
    Doi, Seiji
    Nakatomi, Katsumi
    Iida, Tetsuya
    Hayashi, Tomayoshi
    Nagayasu, Takeshi
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    CLINICAL LUNG CANCER, 2013, 14 (05) : 521 - 526
  • [26] Analysis of EGFR gene mutations in lung adenocarcinoma in Karamay, Xinjiang, China
    Yu-Hua Ma
    Yuan-Xin Li
    Min Jiang
    Jing Gao
    Yi-Ning Lai
    Kamila Kulaixijiang
    Min Zhu
    Fei Liang
    OncologyandTranslationalMedicine, 2023, 9 (05) : 234 - 237
  • [27] Survival of lung adenocarcinoma patients with uncommon EGFR mutations in routine clinical practice in Slovenia
    Stanic, K.
    Hitij, N. Turnsek
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S131 - S132
  • [28] EGFR Amplification and Sensitizing Mutations Correlates with Survival from Erlotinib in Lung Adenocarcinoma Patients
    Ruiz-Patino, A.
    Castro, C.
    Ricaurte, L.
    Cardona, A.
    Rojas, L.
    Zatarain-Barron, Z.
    Wills, B.
    Reguart, N.
    Carranza, H.
    Vargas, C.
    Otero, J.
    Corrales, L.
    Martin, C.
    Archila, P.
    Rodriguez, J.
    Avila, J.
    Bravo, M.
    Pino, L.
    Rosell, R.
    Arrieta, O.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S161 - S162
  • [29] SCREENING FOR THE PREVALENCE OF EGFR AND ALK MUTATIONS IN LUNG ADENOCARCINOMA PATIENTS IN THE LEVANT AREA, A PROSPECTIVE ANALYSIS
    Tfayli, A.
    Khalil, M.
    Mina, A.
    Rafei, H.
    Fakhreddin, N.
    Mahfouz, R.
    Farhat, F.
    Hamouri, S.
    Dbouk, H.
    Zaatari, G.
    ANNALS OF ONCOLOGY, 2015, 26
  • [30] Screening for the prevalence of EGFR and ALK mutations in lung adenocarcinoma patients in the levant area, a prospective analysis
    Tfayli, A.
    Rafei, H.
    Khalil, M.
    Mina, A.
    Fakhreddin, N.
    Mahfouz, R.
    Farhat, F.
    Rabee, H.
    Hamouri, S.
    Dbouk, H.
    Salem, Z.
    Saghir, N.
    Shamseddine, A.
    Bitar, N.
    Mougharbil, A.
    Makarem, J.
    Daw, W.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S30 - S31